Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Applied multimodal diagnostics in a case of presenile dementia

  • Sonja Schönecker1Email authorView ORCID ID profile,
  • Matthias Brendel2,
  • Marion Huber1,
  • Christian Vollmar1,
  • Hans-Juergen Huppertz3,
  • Stefan Teipel4, 5,
  • Nobuyuki Okamura6,
  • Johannes Levin1, 7,
  • Axel Rominger2 and
  • Adrian Danek1
BMC NeurologyBMC series – open, inclusive and trusted201616:131

https://doi.org/10.1186/s12883-016-0647-7

Received: 2 March 2016

Accepted: 26 July 2016

Published: 9 August 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
2 Mar 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
26 Jul 2016 Editorially accepted
9 Aug 2016 Article published 10.1186/s12883-016-0647-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Neurology, Ludwig-Maximilians University, Munich, Germany
(2)
Department of Nuclear Medicine, Ludwig-Maximilians University, Munich, Germany
(3)
Swiss Epilepsy Center, Zurich, Switzerland
(4)
Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany
(5)
German Center for Neurodegenerative Diseases, Rostock, Germany
(6)
Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
(7)
German Center for Neurodegenerative Diseases, Munich, Germany

Advertisement